FOS and metabolic dysfunction-associated steatotic liver disease: Additionally, a strong association between hepatic c‐Fos upregulation and liver dysfunction in MASLD/MASH is apparent when mining metabolic relevance and MASH‐Fibrosis scores, replotted from[18] (Figure 6I).